A seminatural ingredient drug for triglcyeride lowering

  • Robert from Robert DiSilvestro
  • From United States
  • Responsive
  • Investment Opportunities in Startups and Spinoffs

Summary of the technology

A drug combination of 3 USA Generally Regarded as Safe (GRAS), seminatural ingredients is proposed for lowering plasma triglyceride (TG) readings (US and international patents pending). The ingredients are diet components, but have laboratory generated aspects. Some human and animal data exists for TG lowering of each ingredient, but the combination has not been tested. Compared to existing drugs, the newly proposed formula is relatively safe, cost effective, with a low pill burden. The envisioned product could be used alone and added to existing therapies.

Robert DiSilvestro

Details of the Technology Offer

Detailed description is in the attached file.

Intellectual property status

Patent already applied for

Patent application number : Provisional

Where : USA + international options

Current development status

Experimental technologies

Use of Proceeds

$217,ooo for research study

Attached documents

Related Keywords

  • Biological Sciences
  • Medicine, Human Health
  • Pharmaceutical Products / Drugs
  • Medical Health related
  • Clinical Medicine
  • Cardiology

About Me

Biographical Sketch, Dr. Robert DiSilvestro

Dr. DiSilvestro holds a PhD in biochemistry from Texas A&M University, was a nutrition professor for 34 years, and is currently Professor Emeritus of Human Nutrition at The Ohio State University. His research has spanned diverse topics from basic physiology and biochemistry to human intervention studies (which include “non-wet lab” measures in people). This professor has authored/co-authored close to 110 peer reviewed research journal articles, written a number of reviews, composed book chapters, and written a whole book on the state of research for mineral supplements. Dr. DiSilvestro has been on editorial boards for a number of research journals and has been a reviewer for various grant programs (including one for nutrition research with business potential). He has also spoken at a number of nutrition industry trade shows and written for nutrition industry trade journals. He also has done consulting for food and supplement industries (ie. Pepsico, Dupont, and Bausch & Lomb). He also currently runs two startup companies.

Research Accomplishments, Dr. Robert DiSilvestro

My early research emphasized metalloprotein biochemistry and physiology. Some of that work was on copper and zinc transport, which helped set the stage for later explosions in chaperone research. I also developed some metalloenzyme methodology, and was the first to show that moderate mineral deficiencies affect certain metalloenzyme activities. Further work clarified conflicting data on the molecular weight of superoxide dismutase3. Early work also demonstrated that a green tea flavonoid can affect copper enzyme metabolism. At the time, flavonoid bioactivity research was almost nonexistent (a situation that has changed). My mineral work then shifted to applied human nutrition such as finding how to assess marginal deficiencies. The work also compared bioactivities for different versions of minerals. In addition, some consequences of marginal mineral deficiencies were characterized including effects on ADHD children (one article was a cover story for a journal issue).

Eventually, this researcher expanded into nonmineral nutrients and nutraceuticals. Some work examined how well one supplement version fared versus others. In another area, one paper demonstrated that the herb kava was not hepatotoxic. This spawned studies by others that led a European regulatory body reversing a position on kava hepatotoxicity. In other work, a study was done on protein and exercise-induced muscle gain. The resulting paper was the most online accessed research article for the journal for a long time. In a related direction, a series of studies were done on soy products, including one that debunked the idea that they lower testosterone readings in men. Other research showed that by simply eating one apple a day, profound effects are produced for a measure related to heart disease risk. This received wide media coverage.

In various projects, side measures were taken and the data stored. This remains a way to jump start future research. In one case, some natural/semi-natural ingredients were noted to lower triglyceride readings. Three of them are hypothesized to act additively or synergistically.

Robert DiSilvestro

Never miss an update from Robert DiSilvestro

Create your free account to connect with Robert DiSilvestro and thousands of other innovative organizations and professionals worldwide

Robert

Send a request for information
to Robert

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support